NASDAQ
80.95USD
+1.07 (+1.34%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.8B
P/E
—
EPS
—
Beta
0.43
52W range
67.98-99.5
Day range
80.00–82.83
Open
80.56
Prev close
79.88
Volume
228.3K
Avg volume
334.3K
Dividend
0.00
IPO
2000-05-05
https://seekingalpha.com/article/4931688-ani-pharmaceuticals-the-market-is-pricing-the-present-not-the-future · 8/6/2026+0.80
https://www.globenewswire.com/news-release/2026/07/24/3332769/0/en/ANI-Pharmaceuticals-to-Discuss-Second-Quarter-2026-Financial-Results-on-August-7-2026-at-8-00-a-m-ET.html · 7/24/2026+0.00
https://www.proactiveinvestors.com/companies/news/1095359 · 7/13/2026+0.80
https://www.globenewswire.com/news-release/2026/07/13/3326047/0/en/ANI-Pharmaceuticals-Announces-Positive-Six-Month-Topline-Data-from-the-Phase-4-Open-Label-Single-Arm-SYNCHRONICITY-Trial-Evaluating-Fluocinolone-Acetonide-Intravitreal-Implant-in-P.html · 7/13/2026+0.80
https://www.globenewswire.com/news-release/2026/05/27/3301746/0/en/ANI-Pharmaceuticals-to-Present-at-the-2026-Jefferies-Global-Healthcare-Conference.html · 5/27/2026+0.60
https://seekingalpha.com/article/4901415-ani-pharmaceuticals-inc-anip-q1-2026-earnings-call-transcript · 5/8/2026+0.00
https://www.globenewswire.com/news-release/2026/05/08/3290972/0/en/ANI-Pharmaceuticals-Reports-First-Quarter-2026-Financial-Results-and-Raises-2026-Financial-Guidance.html · 5/8/2026+0.80
https://www.zacks.com/stock/news/2908199/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_earnings_esp-2908199 · 4/27/2026+0.60
https://www.globenewswire.com/news-release/2026/04/24/3280674/0/en/ANI-Pharmaceuticals-to-Discuss-First-Quarter-2026-Financial-Results-on-May-8-2026-at-8-00-a-m-ET.html · 4/24/2026+0.30
https://www.globenewswire.com/news-release/2026/04/20/3276833/0/en/ANI-Pharmaceuticals-Announces-the-FDA-Approval-and-Launch-of-Pimozide-Tablets-with-180-Day-CGT-Exclusivity.html · 4/20/2026+0.80
https://www.zacks.com/stock/news/2902639/is-ani-anip-a-solid-growth-stock-3-reasons-to-think-yes · 4/17/2026+1.00
https://www.globenewswire.com/news-release/2026/04/13/3272337/0/en/ANI-Pharmaceuticals-Announces-the-Launch-of-Carbamazepine-Extended-Release-Capsules.html · 4/13/2026+0.80
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
